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        Introduction 
  Checkpoint controls delay cell cycle progression in response 
to conditions that, if uncorrected, generate genetic instability. 
The spindle assembly checkpoint (SAC) prolongs mitosis un-
til all kinetochores are stably attached to spindle microtubules 
(MTs;   Musacchio and Salmon, 2007  ). In brief, the SACs 
  “  wait-anaphase  ”   signal is generated by several proteins, in-
cluding Mad1 and Mad2, that are present on unattached but 
not attached kinetochores. In the presence of unattached or 
weakly attached kinetochores, these proteins catalyze the for-
mation of an inhibitory complex, which is thought to consist 
of Mad2, BubR1/Mad3, Bub3, and Cdc20, that prevents ana-
phase-promoting complexes (APCs) from recognizing and 
ubiquitinating those proteins required for chromatid cohesion 
(shugoshin and securin) and the mitotic state (cyclin B). When 
all kinetochores are under tension, which promotes their satu-
ration with MTs (  Waters et al., 1998  ;   Nicklas et al., 2001  ), the 
checkpoint is satisfi  ed, production of the inhibitory signal 
ceases, and APCs are free to target shugoshin, securin, and cy-
clin B for proteolysis. 
  As for most checkpoints, satisfaction of the SAC is not re-
quired for exiting mitosis: normal (and many cancer) cells that 
enter mitosis in spindle poisons ultimately exit mitosis and enter 
the next G1 as tetraploid cells (  Rieder and Maiato, 2004  ). 
The process by which cells escape mitosis when they cannot 
satisfy the SAC requires the ubiquitination and proteolysis of 
cyclin B and is known as mitotic   “  slippage  ”   (  Hunt et al., 1992  ; 
  Andreassen and Margolis, 1994  ;   Brito and Rieder, 2006  ). 
Several factors infl  uence the rate of slippage including the species 
the cell is from and its genotype. In general, cells from rodents 
are more resistant to spindle poisons and slip through an active 
SAC more rapidly than those from primates (  Kung et al., 1990 ). 
For example, when spindle assembly is inhibited with nocodazole, 
mouse fi  broblasts slip through mitosis in     4 h (  Lanni and Jacks, 
1998  ), whereas human HeLa require   ≥  20 h (  Jordan et al., 1992  ). 
The genotype of the cell is important because many transformed 
cells have a   “  weakened  ”   SAC, caused by a reduced expression 
of or mutations in one or more SAC proteins, that translates into 
an accelerated rate of slippage (  Weaver and Cleveland, 2005  ). 
  The rate of slippage is also correlated with the concentra-
tion of the drug used to poison MT assembly/behavior: as a rule, 
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cannot be satisﬁ  ed, cells exit mitosis via mi-
totic slippage. In microtubule (MT) poisons, 
slippage requires cyclin B proteolysis, and it appears to 
be accelerated in drug concentrations that allow some MT 
assembly. To determine if MTs accelerate slippage, we fol-
lowed mitosis in human RPE-1 cells exposed to various 
spindle poisons. At 37  °  C, the duration of mitosis in no-
codazole, colcemid, or vinblastine concentrations that in-
hibit MT assembly varied from 20 to 30 h, revealing that 
different MT poisons differentially depress the cyclin B de-
struction rate during slippage. The duration of mitosis in 
Eg5 inhibitors, which induce monopolar spindles without 
disrupting MT dynamics, was the same as in cells lacking 
MTs. Thus, in the presence of numerous unattached kineto-
chores, MTs do not accelerate slippage. Finally, compared 
with cells lacking MTs, exit from mitosis is accelerated over 
a range of spindle poison concentrations that allow MT as-
sembly because the SAC becomes satisﬁ  ed on abnormal 
spindles and not because slippage is accelerated.
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direct data. Because this rate also correlates with drug concentration, 
it may be infl  uenced more by the drug than by the presence of 
MTs. Alternatively, drug concentrations that permit the assembly 
of some MTs may, within a range, allow the SAC to ultimately be 
satisfi  ed. To evaluate these possibilities, we conducted a series of 
live cell studies on telomerase immortalized human RPE-1 cells, 
which have a normal and robust SAC, dividing in the presence of 
drugs that perturb spindle formation and/or MT assembly. 
  Results and discussion 
  We used time-lapse phase-contrast light microscopy to follow 
fi  elds of RPE-1 cells for 48  –  72 h at 37  °  C immediately after 
treatment with various concentrations of drugs that disrupt MT/
spindle assembly differently. We then analyzed these records 
(e.g., Video 1, available at http://www.jcb.org/cgi/content/full/
jcb.200805072/DC1) to determine the percentage of dividing 
cells that slipped through mitosis into the next G1 as well as the 
duration of mitosis. For this study, we defi  ned the duration of 
mitosis as that period between the fi  rst frame after nuclear enve-
lope breakdown (NEB) and the fi  rst frame that includes evi-
dence of cytokinesis and/or the telophase membrane blebbing 
that precedes cell refl  attening. 
  In the absence of MTs, the rate of mitotic 
slippage depends on the drug used to 
prevent spindle assembly 
  When RPE-1 cells entered mitosis in 3.2   μ  M nocodazole, a con-
centration established empirically to be near the minimum required 
to completely inhibit spindle MT assembly in these cells, 71% 
slipped into the next G1 as 4N cells (the remaining 29% died in di-
vision), and these survivors spent     19 h on average in mitosis at 
37  °  C (  Fig. 1 A  ,   Table I  , and Video 2, available at http://www.jcb
.org/cgi/content/full/jcb.200805072/DC1). Like nocodazole, 
the lower the drug concentration the faster a cell escapes mitosis 
(  Rieder and Maiato, 2004  ). The reasons for this remain vague. 
However, work on hamster (  Andreassen and Margolis, 1994  ) 
and human nontransformed (  Brito and Rieder, 2006  ) and cancer 
(  Jordan et al., 1992  ) cells reveals that accelerated slippage in 
low drug concentrations correlates with the formation of some 
spindle MTs. For example, rat kangaroo cells entering mitosis 
in 400 nM nocodazole assemble MTs and exit mitosis after    3  h, 
whereas in 10   μ  M nocodazole, MTs fail to form and the cells 
remain in mitosis for     6 h (  Brito and Rieder, 2006  ). That the 
formation of some MTs promotes mitotic slippage is also sug-
gested from results that inhibiting aurora B in taxol or monastrol-
treated HeLa cells, which contain MTs, rapidly drives them out 
of mitosis, whereas nocodazole-treated cells lacking MTs re-
main blocked for hours (  Hauf et al., 2003  ;   Ditchfi  eld et al., 
2003  ). It is also consistent with reports that relative to MT poi-
sons, slippage is promoted by MT-stabilizing drugs like taxol 
(  Andreassen et al., 1996  ;   Chen and Horwitz, 2002  ). 
 These fi  ndings have lead to the idea that the duration of mito-
sis in the presence of MT poisons depends on the number of MTs 
present in the cell (  Weitzel and Vandre, 2000  ). If this is true, then 
MTs positively infl  uence the rate that substrates (like cyclin B) are 
targeted for degradation in the background of an active SAC. This 
could occur, for example, if MTs facilitate the colocalization 
of APCs and their substrates. Indeed, because APCs (  Acquaviva 
et al., 2004  ) and many of their substrates (including cyclin B;   Clute 
and Pines, 1999  ) are associated with the spindle, inhibiting MT 
formation will prevent their colocalization. As noted by  Melloy and 
Holloway (2004)  , although the colocalization of a substrate with 
APCs may not be required for its ubiquitination, this proximity 
may accelerate the timing and specifi  city of the reaction. 
  The conclusion that the rate cells slip through mitosis in the 
presence of an active SAC increases with the level of MT assem-
bly (  Andreassen and Margolis, 1994  ) is, however, based on in-
  Figure 1.       In the absence of spindle MTs, RPE-1 
cells spend 20  –  30 h in mitosis.   Images from 
video records of cells entering and exiting 
mitosis in 3.2   μ  M nocodazole (A), 250 nM 
colcemid (B), 25 nM vinblastine (C), or 1   μ  M 
vinblastine (D). In each sequence, the second 
frame deﬁ  nes the start of mitosis, the third the 
end, and the last depicts the chromosome 
(DNA) and MT pattern in a mitotic cell from a 
similarly treated culture ﬁ  xed and stained for 
the immunoﬂ   uorescence localization of MTs. 
Time from addition of the drug to the medium 
is in minutes. Arrows note the cell that is fol-
lowed in subsequent frames. Bars: (IMF images) 
5   μ  m; (phase images) 20   μ  m.     625 MICROTUBULES AND MITOTIC SLIPPAGE   • Brito et al. 
  When the SAC cannot be satisﬁ  ed, the 
rate of slippage is not accelerated by the 
presence of numerous dynamic spindle MTs 
  At this point, we can conclude that in the absence of MTs, the 
duration of mitosis in RPE-1 cells varies from     20 to 30 h de-
pending on the MT poison. We next asked if the mere presence 
of MTs accelerates mitotic slippage. In our fi  rst study on this 
question, we treated RPE-1 cells entering mitosis with the MT 
  “  stabilizing  ”   drug taxol at a concentration (500 nM) that sup-
presses both MT plus- and minus-end dynamics to the same ex-
tent in vitro (  Derry et al., 1995  ). Under this condition, RPE-1 
cells formed spindles consisting of several (5  –  7) dense astral 
MT arrays linked by their associated chromosomes (  Fig. 2 A  ). 
We found that, on average, these cells remained in mitosis for 
    12 h before refl  attening into multinucleated G1 cells (  Fig. 2 A  ), 
and 81% survived mitosis (  Table I  ). A statistical analysis reveals 
that compared with nocodazole or colcemid-treated RPE-1 cells 
lacking MTs, mitotic slippage was accelerated in the presence 
of 500 nM taxol (P = 0.0002). 
 This  fi  nding is consistent with the conclusions of others 
based on less direct data (  Andreassen and Margolis, 1994  ) and 
implies that the rate of mitotic slippage is accelerated by MTs. 
However, unlike in the absence of MTs, at any time almost all 
kinetochores in taxol-treated cells are stably attached to MTs 
and are not Mad2 positive (  Waters et al., 1998  ). This raises the 
possibility that relative to cells lacking MTs, taxol-treated 
RPE-1 cells spend less time in mitosis because the SAC ulti-
mately becomes satisfi  ed and not because slippage is acceler-
ated. To eliminate this concern, we treated RPE-1 cultures 
with either 5   μ  M S-trityl-  l  -cysteine (  DeBonis et al., 2004  ) or 
2.5   μ  M dimethylenastron (  Gartner et al., 2005  ), two new small 
molecule inhibitors of the kinesin-like Eg5 motor protein that 
are, respectively, 40 and 100 times more potent than monastrol 
(a moderate allosteric Eg5 inhibitor that is used at 100  –  200-  μ  M 
colcemid binds to the    /   -tubulin heterodimer and modifi  es MT 
end dynamics at low concentrations while inducing MT disassem-
bly at high concentrations ( Mollinedo and Gajate, 2003 ). We found 
that 60% of RPE-1 cells that entered mitosis in 250 nM colcemid, 
a concentration empirically established to be near the minimum re-
quired to completely inhibit spindle MT assembly, slipped into G1 
after spending     22 h in mitosis (  Fig. 1 B   and   Table I  ). 
  We next asked how vinblastine infl  uences the duration of 
mitosis. Unlike nocodazole or colcemid, vinblastine prevents MT 
assembly by binding to the     -tubulin subunit of the    /  -tubulin 
heterodimer (  Rai and Wolff, 1996  ). This binding induces a confor-
mational change in tubulin that promotes its self-association into 
aggregates and paracrystals. For this experiment, we used two vin-
blastine concentrations (  Fig. 1, C and D  ): one that prevents spindle 
MT assembly (25 nM) and one that induced small aggregates of 
tubulin and some paracrystals (1   μ  M). We found that 75  –  80% of 
the cells that entered mitosis in both of these concentrations died in 
mitosis after a prolonged period, and those that survived to enter 
the next G1 averaged   30 h in mitosis ( Table I ). When we repeated 
this experiment with 1   μ  M maytansine, which binds to the vinca 
domain of tubulin without inducing paracrystal formation (  Hamel, 
1992  ), we observed the same response: in the absence of MTs, 
RPE-1 cells remained in mitosis for   26 h, during which time 50% 
died (  Table I  ). 
  From these direct data, we conclude that in the absence of 
MTs, the rate that RPE-1 cells slip through an active SAC can differ 
depending on the drug. Compared with the duration of mitosis in 
concentrations of nocodazole (19 h) or colcemid (22 h) that inhibit 
spindle MT assembly, which was the same for both drugs (P = 
0.3335), mitosis was signifi  cantly prolonged in vinblastine (30 h; 
P = 0.0016). This implies that in the background of an active SAC, 
different MT poisons directly or indirectly differentially depress 
either the rate that cyclin B is ubiquitinated during slippage or the 
rate that ubiquitin-tagged cyclin B is destroyed by the proteasome. 
  Table I.       Duration of mitosis in RPE-1 cells exposed to various drugs that perturb spindle formation (37  °  C)   
a   
  Drug/concentration   MTs   Duration of mitosis   ±   SD (N)   
b   Approximate hours in mitosis   
c   Survival 
  %     
d   
Control + 18   ±   3 (33)  0.3 100
3.2   μ  M nocodazole    1,140    ±   732 (25) 19 71
250 nM colcemid    1,303    ±   362 (24) 22 60
25 nM vinblastine    1,784    ±   602 (24)   
e   30 26
1   μ  M vinblastine    1,820    ±   530 (37)  30 21
1   μ  M maytansine    1,558    ±   407 (50)  26 50
500 nM taxol + 744   ±   399 (117)  12 81
5.0   μ  M S-Trityl-  L  -cysteine   
f   + 1,179    ±   310 (160)  20 84
2.5   μ  M dimethylenastron   
g   + 1,218    ±   424 (241) 20 80
50 nM nocodazole + 153   ±   58 (200)  3 100
5 nM vinblastine + 234   ±   140 (180) 4 95
5 nM taxol + 161   ±   85 (171) 3 99
 
a  Minutes from ﬁ  rst frame after NEB to ﬁ  rst frame including the initial signs of cytokinesis and/or telophase membrane blebbing (in cells that exited mitosis).
 
b  N = total numbers of cells (pooled from   ≥  2 separate long-term recordings obtained on different days).
 
c  Mean duration of mitosis in hours.
 
d  Percentage of cells that exited mitosis (versus dying in mitosis).
 
e  These data are from a single experiment.
 
f  An Eg5 inhibitor (and nonnatural derivative of the       –  amino acid cysteine).
 
g  An Eg5 inhibitor (a new monastrol analogue).JCB • VOLUME 182 • NUMBER 4 • 2008  626
then vinblastine (even at 25 nM) signifi  cantly depresses these rates 
(P   <   10 
   8  ), whereas 3.2   μ  M nocodazole or 250 nM colcemid have 
little effect (P = 0.4201 and P = 0.3486, respectively;   Table I  ). 
  Slippage is not accelerated in low 
concentrations of MT poisons. Rather, 
satisfaction of the SAC is delayed on 
abnormal spindles 
  Analyses of fi  xed-cell populations reveal that there is a narrow 
range of concentrations in which MT poisons allow cells to es-
cape mitosis more rapidly in the presence of MTs than they 
would via slippage in the absence of MTs. For example, when 
the percentage of HeLa cells in mitosis after 18  –  20 h is plotted 
against increasing nocodazole concentrations, a rapid rise is 
seen from     2 to 90% between the 10  –  100-nM concentration 
range (  Jordan et al., 1992  ; In HeLa these ranges for vinblastine 
and taxol are, respectively, 0.5  –  10 nM [  Jordan et al., 1991  ] and 
1  –  20 nM [  Jordan et al., 1993  ]). This rapid and progressive rise 
in the mitotic index means that the mean duration of the mitotic 
  “  arrest  ”   increases with increasing nocodazole concentrations 
that, at the structural level, correlate with progressively more 
abnormal spindles. Then, when the concentration reaches the 
upper range limit, the percentage of cells in mitosis reaches its 
maximum (90  –  100%), even as the drug concentration is in-
creased further. At this point, HeLa are blocked in mitosis for at 
least 18  –  20 h, whether they enter mitosis in concentrations of 
nocodazole that allow the formation of highly distorted spindles 
concentrations). Unlike the response to 500 nM taxol, inhibit-
ing Eg5 leads to the formation of monopolar spindles con-
taining near normal numbers of dynamic MTs and numerous 
persistently monooriented chromosomes with Mad2-positive 
kinetochores (  Kapoor et al., 2000  ). We found that 81  –  84% 
of RPE-1 cells entering mitosis in dimethylenastron (  Fig. 2 B   
and Video 3, available at http://www.jcb.org/cgi/content/full/
jcb.200805072/DC1) or S-trityl-  l  -cystine (not depicted) sur-
vived to enter the next G1 after a mean of     20 h in mitosis 
(  Table I  ). Statistical analyses revealed no signifi  cant differ-
ence between the duration of the monopolar mitosis induced 
by dimethylenastron (or S-trityl-  l  -cystine) and the duration of 
mitosis in colcemid- (P = 0.3486) or nocodazole (P = 0.4201)-
treated cells lacking MTs. From these data, we conclude that 
when the SAC cannot be satisfi  ed, the presence of relatively 
normal numbers of dynamic spindle MTs does not accelerate 
mitotic slippage. 
  Because Eg5 inhibitors do not retard spindle formation or 
delay anaphase onset when applied after centrosome separation 
(  Kapoor et al., 2000  ), they do not deleteriously affect cyclin B 
ubiquitination or proteolysis. However, when cells enter mitosis in 
the absence of functional Eg5, the SAC cannot be satisfi  ed (at any 
time   50% of the kinetochores are unattached), and we found that, 
on average,   20 h is required for the cyclin B concentration to drop 
below that needed to sustain the mitotic state. If we use this 20-h 
fi  gure as the normal  “ background ”  rated in RPE-1 cells for cyclin B 
ubiquitination or destruction in the presence of an active SAC, 
  Figure 2.       When RPE-1 cells cannot satisfy the 
SAC, the formation of spindle MTs does not ac-
celerate mitotic slippage.   (A and B) Selected 
images from video recordings of cells entering 
and exiting mitosis in the presence of 500 nM 
taxol (A), which stabilizes spindle MTs, or 2.5   μ  M 
of the Eg5 inhibitor dimethylenastron (B). 
In each sequence the second frame deﬁ  nes the 
start of mitosis, the third the end, and the last 
depicts the chromosome (DNA) and MT pattern 
in a mitotic cell from a similarly treated culture 
ﬁ  xed and stained for the immunoﬂ  uorescence 
localization of MTs. Time from addition of drug 
to the medium is in minutes. See text for de-
tails. Arrows note the cell that is followed in 
subsequent frames. Bars: (IMF images) 5   μ  m; 
(phase images) 20   μ  m.     
  Figure 3.       In low concentrations of MT poi-
sons or stabilizers, RPE-1 cells form aberrant 
spindles that segregate chromosomes into two 
or more daughter cells.   Each row depicts a 
cell entering (second frame) and exiting (third 
frame) mitosis in either 50 nM nocodazole 
(A), 5 nM vinblastine (B), or 5 nM taxol (C). 
The split-screen ﬂ  uorescence images at the end 
of each row depict the distribution of chromo-
somes (DNA) and MTs in cells ﬁ  xed  during 
spindle assembly (ﬁ  fth frame) and telophase/
cytokinesis (sixth). Time from addition of drug 
to the medium is in minutes. Arrows note the 
cell of interest. Bars: (IMF images) 5   μ  m; (phase 
images) 20   μ  m.     627 MICROTUBULES AND MITOTIC SLIPPAGE   • Brito et al. 
99% survived, and   >  90% divided into two or more daughter cells 
(  Fig. 3 C  ). Together, these results confi  rm that, compared with 
drug concentrations that prevent MT assembly, exit from mitosis 
is accelerated in concentrations that allow some MT assembly. 
  As expected, spindle structure in mitotic RPE-1 cells fi  xed 
after 12  –  16 h in 50 nM nocodazole, 5 nM vinblastine, or 5 nM 
taxol varied considerably, from diminished bipolar to distorted 
nonpolar and multipolar spindles (  Fig. 3  ). However, the SAC is 
satisfi  ed once all kinetochores become stably attached to spin-
dle MTs regardless of whether the spindle is structurally normal 
(  Loncarek et al., 2007  ;   Yang et al., 2008  ). In this regard, and 
consistent with our live cell observations, a minor fraction of 
the mitotic cells in these fi  xed cultures contained anaphase or 
telophase spindles (  Fig. 3  ). Yet because some of the APC/Cdc20 
substrates responsible for chromatid cohesion are also de-
stroyed during slippage, including shugoshin (Fig. S1, available 
at http://www.jcb.org/cgi/content/full/jcb.200805072/DC1), 
these anaphase and telophase cells could have been generated 
via accelerated slippage and not from satisfaction of the SAC. 
  To evaluate this possibility, we used immunofl  uorescence 
microscopy to determine if Mad2 or BubR1 are present on any 
anaphase kinetochores in cells treated with 50 nM nocodazole 
or 5 nM taxol. However, because of the large number of kineto-
chores (92), high background staining, and the fact that only 
one signaling kinetochore prevents SAC satisfaction, this study 
proved inconclusive. 
(e.g., 330 nM) or in concentrations (  >  1   μ  M) that completely in-
hibit MT assembly (  Jordan et al., 1992  ). 
  This direct relationship between the drug concentration 
and the duration of the ensuing mitotic block has been inter-
preted to mean that the formation of some spindle MTs ac-
celerates mitotic slippage (Introduction). However, this is not 
consistent with our fi  nding that when the SAC cannot be satisfi  ed, 
mitotic slippage is not accelerated by the mere presence of MTs. 
An alternative, but yet to be tested, interpretation of these data 
is that for MT poisons, a range of concentrations exists in which 
satisfaction of the SAC is retarded but not prevented. In other 
words, within this range MT dynamics are not completely in-
hibited, which ultimately allows all kinetochores to become sat-
urated with MTs regardless of how the spindle is structured. 
  As a fi  rst step toward evaluating this idea, we followed 
mitosis in RPE-1 cells exposed to concentrations of nocodazole 
(50 nM), vinblastine (5 nM), or taxol (5 nM) that lie near the mid-
range supporting accelerated exit from mitosis in HeLa. We found 
that in 50 nM nocodazole, RPE-1 cells averaged     3 h in mitosis 
(vs. 18 min in untreated controls), 100% survived (  Table I  ), and 
90% divided into two or three cells (  Fig. 3 A   and Video 4, avail-
able at http://www.jcb.org/cgi/content/full/jcb.200805072/DC1). 
In 5 nM vinblastine, RPE-1 cells averaged     4 h in mitosis, and 
 > 80% ultimately divided into two or more daughter cells ( Fig. 3 B ). 
Finally, as for HeLa (e.g.,   Ikui et al., 2005  ), RPE-1 cells that en-
tered division in 5 nM taxol averaged     3 h in mitosis (  Table I  ), 
  Figure 4.       Exit from mitosis in the presence 
of low concentrations of spindle MT poisons 
occurs from SAC satisfaction and not slippage.   
(A and B) Selected phase-contrast (top) and ﬂ  uo-
rescence (bottom) frames from video recordings 
of cyclin B/GFP-expressing RPE-1 cells as they 
enter and exit mitosis after no treatment (A) 
or in the presence of 50 nM nocodazole (B). 
Numbers deﬁ  ne the time in minutes from NEB. 
(C) GFP intensity versus time plots reveal that 
the ﬂ  uorescence intensity of control cells (e.g., 
no drug = cell shown in A) begins to rapidly 
decay at metaphase (18 min) after the SAC 
is satisﬁ   ed and, once initiated, the chroma-
tids disjoin     5 min later (23 min; arrow in C). 
A similar behavior is seen in cells treated with 
50 nM nocodazole, except that the rapid de-
cay of ﬂ  uorescence intensity is delayed for a 
variable period during the prolonged mitosis 
(cell in B = cell 3). The cyclin B/GFP intensity 
in cells that enter and exit mitosis in 3.2   μ  M no-
codazole exhibits a slow steady decline, with 
a slope reﬂ  ecting the duration of mitosis, until 
the cell exits mitosis. Bars, 10   μ  m.     JCB • VOLUME 182 • NUMBER 4 • 2008  628
  Materials and methods 
  Stock cultures of RPE-1 cells were maintained at 37  °  C in a humidiﬁ  ed 5% 
CO  2   environment in DME supplemented with 10% FBS. Before each exper-
iment, cells were subcultured onto 25 mm 
2   glass coverslips and grown as 
in the previous sentence for at least 16 h. 
  Before imaging, drugs were added to the medium at the concentra-
tions noted in the text. The drugs used in this study were purchased either 
from Sigma-Aldrich (colcemid, taxol, and vinblastine) or EMD (nocodazole and 
Eg5 Inhibitor III dimethylenastron). Maytansine was provided by the National 
Cancer Institute (Drug Synthesis and Chemistry Branch, Developmental 
Therapeutics Program, Division of Cancer Treatment and Diagnostics). 
  For ﬁ  lming, coverslip cultures were assembled into Rose chambers 
(  Khodjakov and Rieder, 2006  ) containing phenol-free L-15 medium supple-
mented with 10% FBS. Recordings were made at 37  °  C on microscopes 
housed inside custom-built temperature-controlled incubators. Time-lapse im-
ages were captured every 2 (control)  –  10 (experimental) min for 48  –  72 h, 
with a low magniﬁ  cation (10  ×   0.3NA) PlanFluor phase-contrast objective 
lens mounted on a microscope (Diaphot; Nikon) equipped with a video cam-
era (Spot Insight QE) and fast UniBlitz shutters (Vincent Associates). This 
hardware was driven by Image-Pro Plus 5.1.020 (Media Cybernetics, Inc.). 
Image sequences were compiled with ImageJ 1.35c (National Institutes of 
Health), and the contrast was adjusted in Photoshop CS2 (Adobe). 
  Indirect immunoﬂ  uorescence staining for spindle MTs was conducted 
as previously detailed (  Brito and Rieder, 2006  ). After staining, select cells 
were imaged as a Z-series with a microscope (IX70; Olympus) equipped 
with a camera (CM350; Photometrics). The image stacks were then de-
blurred using the SoftWoRx 2.5 deconvolution algorithm (Applied Preci-
sion, LLC) and presented as maximal intensity projections. 
  For cyclin B/GFP studies, RPE-1 cells were cultured and transfected 
as described previously (  Brito and Rieder, 2006  ). 15 h after transfection, 
cells on coverslips were mounted in Rose chambers and cyclin B/GFP-
expressing prophase cells were located and followed through mitosis. 
Near simultaneous phase-contrast and GFP ﬂ  uorescence images were ac-
quired every 1 min for control (no drug) and 3 min for nocodazole-treated 
cells. Images were obtained using a 40  ×   0.75 NA lens on a microscope 
(TE2000E; Nikon) equipped with a shuttered camera (Orca ER; Hama-
matsu Photonics) as well as a narrow band pass excitation filter for 
minimizing GFP photobleaching. Integrated ﬂ  uorescence  intensities  were 
measured by using ImageJ via the method described by   Hoffman et al. 
(2001)  . All intensities were normalized as the ratio to that in the ﬁ  rst (zero) 
time-point image. Surrounding interphase cells expressing cyclin B/GFP 
were used as bystander controls. Data processing and graph plotting were 
conducted in Excel (Microsoft). The cyclin B/GFP construct was provided by 
J. Pines (University of Cambridge, Cambridge, UK). The Sgo1 antibody 
was obtained from Y. Watanabe (University of Tokyo, Tokyo, Japan). 
  Online supplemental material 
  Fig. S1 shows that indirect immunoﬂ   uorescence studies reveal that shu-
goshin (Sgo1) is destroyed as RPE-1 cells slip through mitosis in the pres-
ence of nocodazole or vinblastine. Video 1 shows a low-magniﬁ  cation 
phase-contrast sequence of cultured RPE-1 cells entering and exiting mitosis 
over a period of 3.5 h. Video 2 is similar to video 1, except the culture 
was treated with 3.2   μ  M nocodazole and the framing rate was once 
every 15 min for 50 h. Video 3 is similar to video 1, except the culture 
was treated with 250 nM dimethylenastron and the framing rate was once 
every 10 min. Video 4 is the same as video 1, except the culture was 
treated with 50 nM nocodazole and the framing rate was once every 
10 min. Video 5 shows near-simultaneous phase-contrast (left) and epiﬂ  uo-
rescence (right) sequences of a cyclin B/GFP-expressing RPE-1 cell entering 
and completing mitosis. Video 6 shows near simultaneous phase-contrast 
(left) and epiﬂ   uorescence (right hand) sequences of a cyclin B/GFP-
expressing RPE-1 cell as it enters and exits mitosis in the presence of 50 nM 
nocodazole. Online supplemental material is available at http://www.jcb
.org/cgi/content/full/jcb.200805072/DC1. 
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  In our fi  nal study, we examined the kinetics of cyclin B/
GFP degradation in RPE-1 cells treated with 50 nM nocodazole. 
If it takes several hours to satisfy the SAC in 50 nM nocodazole, 
then the cyclin B/GFP levels should slowly decline because of 
background degradation. But then, as occurs when the SAC is 
satisfi  ed during a normal mitosis, it should suddenly drop pre-
cipitously just before chromatid separation. In contrast, if the 
cells are undergoing accelerated slippage, then cyclin B/GFP 
levels should show a slow steady continuous decline until they 
exit mitosis. As reported previously for HeLa cells (  Clute and 
Pines, 1999  ), satisfaction of the SAC control RPE-1 cells tran-
siently expressing cyclin B/GFP was followed by a sudden steep 
drop in cyclin B/GFP fl  uorescence intensity at metaphase, after 
which the chromatids disjoined 5  –  7 min later (  Fig. 4 A   and 
Video 5, available at http://www.jcb.org/cgi/content/full/jcb
.200805072/DC1). When we repeated this study in the presence 
of 50 nM nocodazole, we consistently obtained a similar result: 
in all fi  ve cells followed from NEB through cytokinesis, the 
cyclin B/GFP fl  uorescence intensity showed a similar slow 
progressive decay after NEB until a variable point,    5-7  min 
before chromatid disjunction/anaphase onset, when it suddenly 
exhibited a sharp and continuous decline (  Fig. 4 B  , Video 6). 
This behavior was also seen in fi  ve other cells in which observa-
tions were initiated after NEB. In contrast, the cyclin B/GFP 
fl  uorescence intensity in cells entering mitosis in 3.2   μ  M no-
codazole exhibited a relatively steady decline, with a slope 
refl  ecting the duration of mitosis, until the cells fi  nally exited 
mitosis 10  –  30 h later (  Fig. 4 C  ;   Brito and Rieder, 2006  ). From 
these experiments, we can conclude that compared with cells 
lacking MTs, cells spend less time in mitosis when exposed to 
low concentrations of spindle poisons because they ultimately 
satisfy the SAC and not because slippage is accelerated. 
  In summary, the rate of mitotic slippage is defi  ned by the 
rate cyclin B is ubiquitinated and destroyed in the background 
of an active SAC. This rate is infl  uenced by the organism the 
cells are from and their genotype. In this paper, we show that 
mitotic slippage in human cells with a normal robust SAC re-
quires     20 h under conditions that do not infl  uence the back-
ground level of cyclin B destruction and also that some drugs 
(notably vinblastine) considerably delay slippage. This delay 
could refl  ect a retardation in the background rate that cyclin B 
is ubiquitinated, either via the APC or some other E3 ubiquitin 
ligase (e.g., NIPA;   Bassermann et al., 2005  ), or its rate of de-
struction by proteolysis. Contrary to conclusions from indirect 
data, our live cell work reveals that the presence of numerous 
dynamic spindle MTs does not infl  uence the rate of slippage. 
Instead, for drugs that perturb MT assembly a range of concen-
trations exists in which, rather than being arrested, mitosis is 
simply prolonged until all of the kinetochores become stably at-
tached to an abnormal spindle (i.e., until the SAC is satisfi  ed). 
Above this concentration the SAC cannot be satisfi  ed, even in 
the presence of some MTs, before the cell exits mitosis via slip-
page. Our fi  nding that cells satisfy the SAC in low concentra-
tions of MT poisons may be clinically relevant. It implies that 
drugs like taxol do not work in situ by arresting cells in mitosis 
and also that during therapy, such drugs can induce high num-
bers of genetically abnormal cells. 629 MICROTUBULES AND MITOTIC SLIPPAGE   • Brito et al. 
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